142 related articles for article (PubMed ID: 38064517)
21. Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort Study.
Jordan A; Toennesen LL; Eklöf J; Sivapalan P; Meteran H; Bønnelykke K; Ulrik CS; Stæhr Jensen JU
J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2096-2103.e1. PubMed ID: 36948487
[TBL] [Abstract][Full Text] [Related]
22. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
23. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.
Benard B; Bastien V; Vinet B; Yang R; Krajinovic M; Ducharme FM
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28818882
[TBL] [Abstract][Full Text] [Related]
24. The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea's National Health Insurance Sharing Service Database.
Kim JH; Lee H; Jeong D; Lee JH; Kwon HS; Song WJ; Cho YS; Kim YJ; Shin YW; Kim TB
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3690-3699.e7. PubMed ID: 37660732
[TBL] [Abstract][Full Text] [Related]
25. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma.
Wechsler ME; Finn D; Gunawardena D; Westlake R; Barker A; Haranath SP; Pauwels RA; Kips JC; Drazen JM
Chest; 2000 Mar; 117(3):708-13. PubMed ID: 10712995
[TBL] [Abstract][Full Text] [Related]
26. Montelukast in pediatric asthma management.
Walia M; Lodha R; Kabra SK
Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
[TBL] [Abstract][Full Text] [Related]
27. A subgroup analysis of the MONICA study: a 12-month, open-label study of add-on montelukast treatment in asthma patients.
Virchow JC; Mehta A; Ljungblad L; Mitfessel H
J Asthma; 2010 Nov; 47(9):986-93. PubMed ID: 20858152
[TBL] [Abstract][Full Text] [Related]
28. Montelukast and emotional well-being as a marker for depression: results from 3 randomized, double-masked clinical trials.
Holbrook JT; Harik-Khan R
J Allergy Clin Immunol; 2008 Oct; 122(4):828-829. PubMed ID: 18760460
[No Abstract] [Full Text] [Related]
29. Should we use montelukast in wheezy children?
Haq I; Harris C; Taylor J; McKean MC; Brodlie M
Arch Dis Child; 2017 Nov; 102(11):997-998. PubMed ID: 28780506
[No Abstract] [Full Text] [Related]
30. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
31. Adverse drug reactions affecting treatment adherence in first-line treatment of asthma: An observational study.
Erdem SB; Nacaroglu HT; Can D
Allergol Immunopathol (Madr); 2023; 51(2):11-16. PubMed ID: 36916083
[TBL] [Abstract][Full Text] [Related]
32. Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?
Miceli Sopo S; Onesimo R; Radzik D; Scala G; Cardinale F
Allergol Immunopathol (Madr); 2009; 37(1):26-30. PubMed ID: 19268058
[No Abstract] [Full Text] [Related]
33. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
34. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P
Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of step-down therapy from an inhaled steroid to montelukast in childhood asthma.
Ciółkowski J; Mazurek H; Stasiowska B
Allergol Immunopathol (Madr); 2014; 42(4):282-8. PubMed ID: 23684855
[TBL] [Abstract][Full Text] [Related]
36. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
37. [Montelukast in the treatment of mild to moderate persistent asthma].
Bellecoste V; Devouassoux G; Pacheco Y
Rev Mal Respir; 2011 Jun; 28(6):706-29. PubMed ID: 21742233
[TBL] [Abstract][Full Text] [Related]
38. Asthma therapy in pediatric patients: a systematic review of treatment with montelukast versus inhaled corticosteroids.
Massingham K; Fox S; Smaldone A
J Pediatr Health Care; 2014; 28(1):51-62. PubMed ID: 23312367
[TBL] [Abstract][Full Text] [Related]
39. Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?
Jartti T
Eur J Pediatr; 2008 Jul; 167(7):731-6. PubMed ID: 18214538
[TBL] [Abstract][Full Text] [Related]
40. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
